GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Abroad (travel likely)RecruitingPHASE1

Conditions

Alveolar Soft Part Sarcoma · Renal Cell Carcinoma · Triple Negative Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Arthur J.E. Child Comprehensive Cancer Centre, Calgary, Alberta, Canada
Contact: Study coordinator (Mona Shafey) · 403 944-8047
University Health Network, Toronto, Ontario, Canada
Contact: Study coordinator (Abdulazeez Salawu) · 416 946-4501

Study leads

Mona Shafey
Study Chair
Tom Baker Cancer Centre, Calgary, Alberta, Canada

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Locally Advanced Alveolar Soft Part Sarcoma · Metastatic Alveolar Soft Part Sarcoma · Locally Advanced Non Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE1

Bethesda, United States

AB122 Platform Study

Advanced or Metastatic Solid Tumor · Pancreatic Ductal Adenocarcinoma · Colorectal Cancer

Abroad (travel likely)RecruitingPHASE1

Aichi, Japan · Chiba, Japan

Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial

Advanced Alveolar Soft Part Sarcoma · Advanced Soft Tissue Sarcoma · Metastatic Alveolar Soft Part Sarcoma

Abroad (travel likely)RecruitingPHASE2

Los Angeles, United States · Los Angeles, United States

Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

Neuroblastoma · Rhabdomyosarcoma · Synovial Sarcoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Gainesville, United States